Yasuhiro Maeda Selected Research

Yasuhiro Maeda Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 05/2005
11	Erectile Dysfunction 10/2022 - 03/2011
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2019 - 05/2005
9	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2015 - 01/2007
7	Philadelphia Chromosome 04/2024 - 05/2005
7	Multiple Sclerosis 12/2020 - 05/2002
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 03/2009
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2018 - 07/2003
4	Inflammation (Inflammations) 01/2021 - 05/2014
4	Hypertension (High Blood Pressure) 01/2020 - 09/2009
4	Fibrosis (Cirrhosis) 01/2020 - 01/2003
4	Autoimmune Diseases (Autoimmune Disease) 07/2017 - 02/2006
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2022 - 12/2020
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2020 - 07/2017
3	Hypothermia 01/2018 - 07/2013
3	Human Influenza (Influenza) 01/2018 - 10/2012
3	Infections 01/2018 - 01/2007
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015 - 12/2004
3	Type 2 Diabetes Mellitus (MODY) 04/2014 - 04/2009
3	Lymphoma (Lymphomas) 05/2012 - 02/2009
3	Peritoneal Fibrosis 01/2008 - 01/2003
2	Diabetes Mellitus 09/2022 - 09/2009
2	Disease Progression 01/2022 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2019
2	Autonomic Nervous System Diseases (Dysautonomia) 11/2021 - 01/2021
2	Myasthenia Gravis 04/2021 - 05/2020
2	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 07/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 05/2014
2	Bradycardia 01/2017 - 09/2015
2	Optic Neuritis (Retrobulbar Neuritis) 01/2016 - 04/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014 - 03/2010
2	Leukemia 01/2014 - 10/2008
2	T-Cell Leukemia (Leukemia, T Cell) 04/2013 - 06/2008
2	Hemorrhage 12/2010 - 03/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2010 - 02/2009
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2009 - 07/2008

Drug/Important Bio-Agent (IBA)

16	AntibodiesIBA 09/2022 - 10/2002
9	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 05/2005
7	AutoantibodiesIBA 12/2020 - 02/2009
5	Tyrosine Kinase InhibitorsIBA 04/2024 - 04/2012
5	Tryptophan (L-Tryptophan)FDA Link 03/2021 - 06/2015
5	Oseltamivir (Tamiflu)FDA Link 01/2018 - 10/2012
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016 - 07/2013
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2017
4	Rituximab (Mabthera)FDA Link 02/2022 - 01/2010
4	Cholinergic ReceptorsIBA 11/2021 - 01/2016
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017 - 02/2006
4	Erythropoietin FDA Link 04/2016 - 10/2002
4	Messenger RNA (mRNA)IBA 10/2009 - 05/2002
4	AdiponectinIBA 09/2009 - 02/2009
3	SaltsIBA 01/2020 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2017
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019 - 01/2017
3	amiselimodIBA 01/2019 - 01/2017
3	Azacitidine (5 Azacytidine)FDA Link 10/2018 - 01/2014
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016 - 12/2004
3	nilotinib FDA Link 04/2012 - 06/2009
3	Sirolimus (Rapamycin)FDA Link 10/2009 - 07/2003
3	RV 538 (PDMP)IBA 09/2009 - 02/2009
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2008 - 03/2007
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2008 - 01/2003
2	Testosterone (Sustanon)FDA Link 10/2022 - 12/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022 - 01/2021
2	PlatinumIBA 04/2022 - 10/2008
2	Bendamustine Hydrochloride FDA Link 02/2022 - 08/2021
2	EnzymesIBA 03/2021 - 09/2020
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 03/2021 - 01/2018
2	NADP (NADPH)IBA 01/2021 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 01/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 01/2019
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 03/2011
2	CreatinineIBA 01/2020 - 09/2009
2	Arginine (L-Arginine)FDA Link 01/2020 - 01/2019
2	Immunoglobulin G (IgG)IBA 06/2019 - 10/2016
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 01/2017
2	Therapeutic UsesIBA 01/2019 - 08/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 10/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2010
2	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2017 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 04/2014
2	Immunoglobulin M (IgM)IBA 05/2017 - 01/2007
2	Peptides (Polypeptides)IBA 10/2016 - 04/2016
2	EpitopesIBA 10/2016 - 04/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 05/2002
2	SteroidsIBA 04/2015 - 12/2010
2	Neuraminidase (Sialidase)IBA 02/2015 - 07/2013
2	CitrullineIBA 06/2014 - 10/2013
2	CytokinesIBA 05/2014 - 01/2007
2	Vardenafil Dihydrochloride (Levitra)FDA Link 07/2012 - 03/2011
2	Carnitine (L-Carnitine)FDA LinkGeneric 08/2010 - 12/2007
2	ChemokinesIBA 09/2009 - 09/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2009 - 02/2009
2	Eicosapentaenoic AcidIBA 04/2009 - 02/2009

Therapy/Procedure

25	Therapeutics 04/2024 - 01/2004
6	Drug Therapy (Chemotherapy) 04/2024 - 05/2005
5	Immunotherapy 03/2021 - 01/2008
2	Hematopoietic Stem Cell Transplantation 04/2013 - 10/2010
2	Remission Induction 03/2010 - 03/2007
2	Renal Dialysis (Hemodialysis) 01/2010 - 10/2002